1. Home
  2. TECX vs COFS Comparison

TECX vs COFS Comparison

Compare TECX & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • COFS
  • Stock Information
  • Founded
  • TECX 2019
  • COFS 1898
  • Country
  • TECX United States
  • COFS United States
  • Employees
  • TECX N/A
  • COFS N/A
  • Industry
  • TECX
  • COFS Major Banks
  • Sector
  • TECX
  • COFS Finance
  • Exchange
  • TECX Nasdaq
  • COFS Nasdaq
  • Market Cap
  • TECX 387.1M
  • COFS 454.9M
  • IPO Year
  • TECX 2018
  • COFS N/A
  • Fundamental
  • Price
  • TECX $23.51
  • COFS $29.98
  • Analyst Decision
  • TECX Strong Buy
  • COFS Strong Buy
  • Analyst Count
  • TECX 5
  • COFS 2
  • Target Price
  • TECX $79.00
  • COFS $39.00
  • AVG Volume (30 Days)
  • TECX 230.2K
  • COFS 63.2K
  • Earning Date
  • TECX 08-07-2025
  • COFS 07-25-2025
  • Dividend Yield
  • TECX N/A
  • COFS 3.71%
  • EPS Growth
  • TECX N/A
  • COFS N/A
  • EPS
  • TECX N/A
  • COFS 1.30
  • Revenue
  • TECX N/A
  • COFS $108,378,000.00
  • Revenue This Year
  • TECX N/A
  • COFS $78.93
  • Revenue Next Year
  • TECX N/A
  • COFS $9.11
  • P/E Ratio
  • TECX N/A
  • COFS $23.30
  • Revenue Growth
  • TECX N/A
  • COFS 30.36
  • 52 Week Low
  • TECX $13.70
  • COFS $24.89
  • 52 Week High
  • TECX $61.07
  • COFS $38.15
  • Technical
  • Relative Strength Index (RSI)
  • TECX 56.50
  • COFS 55.39
  • Support Level
  • TECX $21.31
  • COFS $28.42
  • Resistance Level
  • TECX $23.12
  • COFS $30.66
  • Average True Range (ATR)
  • TECX 1.53
  • COFS 0.77
  • MACD
  • TECX 0.13
  • COFS 0.13
  • Stochastic Oscillator
  • TECX 71.85
  • COFS 69.64

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

Share on Social Networks: